...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: RBC unregistered to registered account

RVXoldtimer - So just to clarify an IPO is an M&A transaction and shares of ZEL would be dividended out to the corresponding shareholders.

tada

Share
New Message
Please login to post a reply